Nanobiotix S.A. (LON:0QAV)
London · Delayed Price · Currency is GBP · Price in EUR 20.80
+0.30 (1.46%)
Feb 12, 2026, 4:27 PM GMT
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of 866.23 million as of February 12, 2026. Its market cap has increased by 546.63% in one year.
Market Cap
866.23M
Enterprise Value
885.76M
Revenue
8.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.80
Market Cap Chart
Since October 29, 2012, Nanobiotix's market cap has increased from 53.24M to 866.23M, an increase of 1,527.05%. That is a compound annual growth rate of 23.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 866.23M | 5.25% |
| Dec 31, 2025 | 822.99M | 594.23% |
| Dec 31, 2024 | 118.55M | -56.33% |
| Dec 29, 2023 | 271.46M | 142.59% |
| Dec 30, 2022 | 111.90M | -47.64% |
| Dec 31, 2021 | 213.73M | -49.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 231.18B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 11.10B |
| Oxford Nanopore Technologies | 1.29B |
| Oxford Biomedica | 986.00M |
| CVS Group | 982.18M |
| Spire Healthcare Group | 800.72M |